Mikashmi Kohli completed her PhD in Molecular Medicine from the All India Institute of Medical Sciences, New Delhi, and did her postdoctoral fellowship at McGill University with the Pai Global TB group. Working with the Cochrane Systematic Review team on diagnostic accuracy of molecular tests in TB, she has training in evidence-based medicine and has also contributed to the WHO policy work related to TB diagnostics. She has been part of several Guideline Development groups for TB diagnostics.

She has have served on the Lancet commission on diagnostics where my work on cascade of care for different diseases and cost modelling was key in summarizing the Commission recommendations. She has also been involved in assessing quality of healthcare in India, Peru, South Africa, and Sierra-Leone which have helped countries in assessing the needs for generating national essential diagnostics list.

She has led several projects related to accuracy of molecular TB diagnostics, and also to assess availability and accessibility of diagnostics in primary healthcare settings in low and-middle income countries. She is passionate about evidence driven policies and implementation strategies for diagnostics in Global Health.